QualityStocksNewsBreaks Archives - Page 2 of 1338

WednesdayJan 15, 2025 8:00 am

QualityStocksNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Reports Financial Results and Waterberg Project Progress

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) announced financial results for the three months ended Nov. 30, 2024, and provided updates on its Waterberg Project in South Africa. The mechanized, shallow mine is designed to produce platinum, palladium, rhodium, and gold ("PGMs") alongside copper and nickel by-products, aiming to be among the world's largest and most cost-effective underground PGM operations. Near-term objectives include advancing to a development decision, securing construction financing, and finalizing concentrate offtake agreements. Additionally, the company continues collaborating with Anglo American Platinum and Florida International University through Lion Battery Technologies Inc. to integrate platinum and palladium…

TuesdayJan 14, 2025 12:45 pm

QualityStocksNewsBreaks – Adageis Featured in BioMedWire Podcast

Adageis was featured in the latest episode of the BioMedWire Podcast, as part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Shane Speirs, CEO of Adageis, joined the program to provide an introduction to the company’s business model. “Healthcare is a complicated place, and navigating the system is extremely difficult for patients. On the healthcare delivery side, it's also tough. Classically, there have been different reimbursement methods for healthcare services in the United States, but many agree the future is value-based care,” Speirs explained. “What Adageis does is provide a simple solution to healthcare organizations…

TuesdayJan 14, 2025 12:20 pm

QualityStocksNewsBreaks – VenHub Global Inc. Launches First Autonomous Smart Store in North Hollywood

VenHub, an emerging AI and robotics technology company, has announced the opening of its first fully autonomous Smart Store, now live at 11720 Vanowen Street in North Hollywood, California. The store was sold to one of VenHub’s valued customers who is excited to introduce a next-generation shopping experience to the local community. “I want to thank our shareholders and our partners for their support, and I also want to recognize the entire VenHub team for their passion, hard work and dedication to creating a Smart Store that will change the retail landscape for generations,” said Shahan Ohanessian, CEO of VenHub.…

TuesdayJan 14, 2025 8:45 am

QualityStocksNewsBreaks – PaxMedica Inc. (PXMD) Secures Patent Approval in China for Autism Treatment

PaxMedica (OTC: PXMD), a clinical-stage biopharmaceutical company focused on neurological disorders, has received a Notification to Grant Patent Right for its Chinese invention patent application (No: 2020800553323). The patent covers compositions and methods for treating cognitive, social, or behavioral disabilities and neurodevelopmental disorders, including autism, using a novel intranasal suramin formulation. CEO Howard Weisman highlighted this as a historic milestone, marking the first intellectual property protection for suramin in over a century. PaxMedica plans to pursue similar protections in additional jurisdictions, including the United States. To view the full press release, visit https://ibn.fm/sn3b4 About PaxMedica Inc. PaxMedica is a forward-looking,…

TuesdayJan 14, 2025 7:35 am

QualityStocksNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) to Present Breakthrough Virotherapy Platform at AACR 2025

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company specializing in targeted antitumor virotherapies, announced its abstract, "Development of a Systemic Enveloped Virotherapy for Targeting All Metastatic Sites," has been accepted for presentation at the American Association for Cancer Research ("AACR") Annual Meeting, April 25-30, 2025, in Chicago. The presentation will highlight Calidi’s proprietary RTNova systemic platform, which leverages a novel vaccinia virus strain enveloped with a human cell membrane to overcome immune system elimination, enabling targeted delivery to multiple metastatic tumor sites. This innovative approach aims to address treatment challenges in advanced metastatic cancers, such as lung cancer, where…

TuesdayJan 14, 2025 7:30 am

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Refutes NVIDIA CEO’s Quantum Computing Comments on CNBC

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, announced that CEO Dr. Alan Baratz appeared on CNBC’s “The Exchange” on January 8th to address recent comments by NVIDIA CEO Jensen Huang regarding quantum computing’s readiness. Dr. Baratz clarified that D-Wave’s annealing quantum computing systems are already commercially available and solving real-world problems, unlike gate-model quantum computers, which may still face significant development timelines. He highlighted D-Wave’s success in optimization problems, such as materials simulations, and emphasized the company’s work with a multitude of customers that are using D-Wave technology today to solve complex…

MondayJan 13, 2025 2:56 pm

QualityStocksNewsBreaks – Adageis’s Platform Empowering Organizations to Adjust to New Risk-Scoring Dynamics

Adageis, a forward-thinking healthcare technology company reshaping patient care through flexible AI-centric software solutions, is in support of the Centers for Medicare and Medicaid Services’ (“CMS”) switching from the V24 to the V28 upgrade of the Hierarchical Condition Categories (“HCC”) model. “The transition from CMS-HCC V24 to V28 reflects a critical update to the risk adjustment model used in Medicare Advantage… The more precise structure enhances diagnostic specificity, allowing for better patient categorization. This change supports value-based care by tying payments more closely to actual patient needs,” reads a recent article. “The CMS-HCC transition aligns closely with Adageis’s mission of…

MondayJan 13, 2025 1:48 pm

QualityStocksNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Eyes Opportunity in Race to Establish AI Sector Infrastructure

McEwen Mining (NYSE: MUX) (TSX: MUX) was highlighted in a recent article that discussed favorable positioning of the United States in the AI sector. “Sam Altman, the CEO of OpenAI, has voiced his confidence in President-elect Donald Trump supporting the AI sector and ensuring that America, together with its allies, retain pole position in this nascent industry. Altman was speaking during a recent interview with Fox News,” the publication reads. “During the interview, Altman highlighted the need for support in the form of massive infrastructure… for the U.S. to stamp its leadership on AI technology and AI capabilities.” “Tech giants like…

MondayJan 13, 2025 11:10 am

QualityStocksNewsBreaks – ROTH Adds Five Strategic Hires to Its Sales and Trading Team

Roth Capital Partners, LLC (“ROTH”) has announced the expansion of its sales and trading team with five seasoned professionals: Todd Trimmer, Nathan Cahill, Ken Hawkins, Matthew Job, and Michael Shea. “These strategic hires exemplify ROTH’s commitment to expanding teams of professionals across departments and advancing our mission to deliver unparalleled service, innovation and growth for clients and stakeholders alike,” said Sagar Sheth, CEO of ROTH, highlighting the significance of these additions. To view the full press release, visit https://ibn.fm/Gp5aV About ROTH ROTH is a relationship-driven investment bank focused on serving growth companies and their investors. Its full-service platform provides capital…

MondayJan 13, 2025 7:30 am

QualityStocksNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Prices $4.25 Million Public Offering

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company focused on targeted immunotherapies, has priced its public offering of 5,000,000 shares of common stock at $0.85 per share, with gross proceeds expected to total approximately $4.25 million before fees and expenses. The offering, exclusively placed by Ladenburg Thalmann & Co. Inc., is set to close on or around Jan. 10, 2025, subject to customary conditions. Proceeds will support working capital and general corporate purposes. The shares are offered under an effective Form S-3 registration statement, with a final prospectus available on the SEC's website or through Ladenburg Thalmann. To view…

Site Search

Company Search

Category: QualityStocksNewsBreaks